Birth of cyber-collaboration
Mollie Shields-Uehling, president and CEO of SAFE-BioPharma Association, explains how the industry’s interests in collaboration and cloud computing…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
27 Mar 13
Mollie Shields-Uehling, president and CEO of SAFE-BioPharma Association, explains how the industry’s interests in collaboration and cloud computing…
27 Mar 13
Paul Ludorf of Rottapharm looks at how the use of software systems by the first generation of digital…
26 Mar 13
Following a period of decline in delivery, and in anticipation of major regulatory ructions, PwC’s Steve Arlington, Myrto…
11 Mar 13
Pharmaceutical and biotechnology companies are increasingly considering adaptive strategies in clinical trials, but what do they entail? Dr…
11 Mar 13
Although Eastern Europe offers challenges, it is increasingly being viewed as an attractive region to outsource clinical research…
11 Mar 13
Recruiting the right sample group is crucial to the outcome of a trial but the process can be…
11 Mar 13
Supply of clinical trial material (CTM), on time, in full, in the right place and of the right…
07 Mar 13
Selecting the right contract research organisation (CRO) is a critical decision for any pharmaceutical company looking to bring…
07 Mar 13
The rise of CROs and the outsourcing of clinical trials are presenting clinical data managers with a variety…
07 Mar 13
As the pharmaceutical industry faces growing public demand for greater transparency in the publication of drug trial results,…